07/29/2025
3:15 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2025
10:22 AM | Aclaris Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G | |
07/24/2025
3:21 PM | Aclaris Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13G/A | |
07/17/2025
6:44 PM | Aclaris Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G | |
06/30/2025
5:59 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2025
3:20 PM | Aclaris Therapeutics (Issuer)
Molineaux Christopher P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:20 PM | Aclaris Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:20 PM | Aclaris Therapeutics (Issuer)
Humphries William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:20 PM | Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:20 PM | Aclaris Therapeutics (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:20 PM | Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ACRS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/05/2025
4:01 PM | Aclaris Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/15/2025
9:45 AM | Aclaris Therapeutics (Subject)
Rock Springs Capital Management LP (Filed by)
| Form SCHEDULE 13G/A | |
05/12/2025
8:07 AM | Aclaris Therapeutics (Subject)
Adage Capital Management, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
05/08/2025
3:30 PM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2025
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2025
3:32 PM | Aclaris Therapeutics (Issuer)
Hall Jesse Wayne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:00 PM | Aclaris Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13G | |
04/24/2025
6:00 AM | Aclaris Therapeutics (Filer)
| Form DEF 14A | |
04/24/2025
6:01 AM | Aclaris Therapeutics (Filer)
| Form DEFA14A | |
04/24/2025
6:01 AM | Aclaris Therapeutics (Filer)
| Form ARS | |
03/09/2025
11:15 PM | Aclaris Therapeutics (Filer)
| Form EFFECT | |
02/27/2025
3:30 PM | Aclaris Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
6:17 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
1:26 PM | Aclaris Therapeutics (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/12/2025
8:31 AM | Aclaris Therapeutics (Subject)
Adage Capital Management, L.P. (Filed by)
| Form SCHEDULE 13G | |
01/13/2025
6:00 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
5:25 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:25 PM | Aclaris Therapeutics (Issuer)
Loerop James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:25 PM | Aclaris Therapeutics (Issuer)
Balthaser Kevin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:25 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/01/2025
11:15 PM | Aclaris Therapeutics (Filer)
| Form EFFECT | |
12/31/2024
3:15 PM | Aclaris Therapeutics (Filer)
| Form 424B3 | |
12/19/2024
3:31 PM | Aclaris Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/12/2024
3:15 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
3:15 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2024
7:06 AM | Aclaris Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/03/2024
4:42 PM | Aclaris Therapeutics (Issuer)
Davis Hugh M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
3:02 PM | Aclaris Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/25/2024
10:02 AM | Aclaris Therapeutics (Subject)
Biosion, Inc. (Filed by)
| Form SC 13G | |
11/25/2024
10:03 AM | Aclaris Therapeutics (Issuer)
Biosion, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Crypto bros: Meet your replacement (Ad) Larry Benedict made $274 million trading on Wall Street…
Barron’s ranked his hedge fund in the top 1% worldwide.
Now he’s applying the same expertise to the Bitcoin market.
His system tracks 19 indicators to find quick Bitcoin profit opportunities. Now he’s revealing the entire thing… FREE. |
11/21/2024
3:51 PM | Aclaris Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G | |
11/20/2024
3:20 PM | Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
3:20 PM | Aclaris Therapeutics (Issuer)
Davis Hugh M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/18/2024
7:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
6:21 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
3:18 PM | Aclaris Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
10/03/2024
3:15 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
6:52 PM | Aclaris Therapeutics (Issuer)
Balthaser Kevin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
4:08 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:15 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
3:30 PM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free ACRS Stock Alerts